KDK
CXM
BRZE
CSBR
AMPL

Scott R. Tobin

Known title: 10% OwnerCIK: 0001199926

Associated companies

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 16, 2026

Kodiak AI Launches Autonomous Laredo Lane, Sets Q3 Earnings Date. Kodiak AI has launched a new autonomous freight lane with Charger Logistics, marking a practical step in its self-driving trucking operations. The company also announced it will report third-quarter 2026 financial results on November 5. These developments provide concrete updates on business progress ahead of the upcoming earnings release.

this person other insiders at KDK

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

Sprinklr Q2 Results Reviewed Against Peers. Recent analysis benchmarked Sprinklr's second-quarter performance against other sales and marketing software companies. This review provides context for how the company is positioned within its sector relative to peers. The stock currently trades within a wide 52-week range, with an average analyst target price of $8.44.

this person other insiders at CXM

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 11, 2026

Braze Shares Rise Amid Analyst Support and Valuation Focus. Braze stock has seen a recent surge, drawing attention in reports on undervalued tech names. Citizens Bank reiterated a Market Outperform rating with a $35 price target, aligning with the broader analyst consensus of $37.30. This positive sentiment supports the stock's movement within its 52-week range of $15.26 to $37.33.

this person other insiders at BRZE

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 29, 2026

Champions Oncology Highlighted in Global PDX Models Shift. Champions Oncology was highlighted in a Yahoo article that discusses the shift toward patient‑derived xenograft (PDX) models in precision oncology. The story compares the company with peers like Charles River, Crown Bioscience, The Jackson Laboratory and Oncodesign, indicating growing industry focus on PDX‑based research. This comparison suggests Champions may benefit from increased demand for its precision oncology solutions. No new financial data were disclosed.

this person other insiders at CSBR

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

October 14, 2026

Amplitude (AMPL) noted for AI push and share surge. Recent coverage highlights Amplitude’s focus on AI and enterprise customers, with analysts suggesting the stock may be trading about 14% above its fair value. At the same time, the company’s shares joined a broader rally of AI‑related stocks, posting notable gains. The attention underscores market interest in the firm’s growth strategy.

this person other insiders at AMPL

Transaction History

KDK▲ Buy$0
KDK▲ Buy—
KDK▲ Buy—
CXM▼ Sell$0
CXM▼ Sell$0
BRZE▼ Sell—
BRZE▼ Sell—
CXM▼ Sell$0
BRZE▼ Sell$706K
BRZE▼ Sell$851K
BRZE▼ Sell$34K
BRZE▼ Sell$41K
CXM▼ Sell$0
CSBR▲ Buy$32K
AMPL▼ Sell$147K
AMPL▼ Sell$463K
AMPL▼ Sell$616K
AMPL▼ Sell$119K
AMPL▼ Sell$142K
CSBR▲ Buy$16K

We use analytics to understand how market-wall is used. No personal data is sold.